Published June 2013 | Version v1
Journal article

Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT

  • 1. Department of Basic Medical Sciences, Ghent University, Gent (Belgium)
  • 2. Department of Radiation Oncology, Ghent University Hospital, Gent (Belgium)

Description

Purpose: To investigate whether rotational techniques (Volumetric Modulated Arc Therapy – VMAT) are associated with a higher risk for secondary primary malignancies compared to step-and-shoot Intensity Modulated Radiation Therapy (ss-IMRT). To this end, radiation therapy (RT) induced DNA double-strand-breaks and the resulting chromosomal damage were assessed in peripheral blood T-lymphocytes of prostate cancer (PCa) patients applying γH2AX foci and G0 micronucleus (MN) assays. Methods and materials: The study comprised 33 PCa patients. A blood sample was taken before start of therapy and after the 1st and 3rd RT fraction to determine respectively the RT-induced γH2AX foci and MN. The equivalent total body dose (DETB) was calculated based on treatment planning data. Results: A linear dose response was obtained for γH2AX foci yields versus DETB while MN showed a linear-quadratic dose response. Patients treated with large volume (LV) VMAT show a significantly higher level of induced γH2AX foci and MN compared to IMRT and small volume (SV) VMAT (p < 0.01). Assuming a linear-quadratic relationship, a satisfactory correlation was found between both endpoints (R2 0.86). Conclusions: Biomarker responses were governed by dose and irradiated volume of normal tissues. No significant differences between IMRT and rotational therapy inherent to the technique itself were observed

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2013.05.014

Additional details

Identifiers

DOI
10.1016/j.radonc.2013.05.014;
PII
S0167-8140(13)00228-4;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
107
Journal Issue
3
Journal Page Range
p. 377-381
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
45088239
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BIOLOGICAL MARKERS; DNA; NEOPLASMS; PROSTATE; RADIATION DOSES; RADIOTHERAPY; STRAND BREAKS
Descriptors DEC
BODY; DISEASES; DNA DAMAGES; DOSES; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANS; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.